HBX — HBX International Income Statement
0.000.00%
- €1.80bn
- €2.20bn
- €778.00m
- 46
- 44
- 13
- 22
Annual income statement for HBX International, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.
2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 461 | 696 | 743 | 778 |
| Cost of Revenue | ||||
| Gross Profit | 403 | 633 | 685 | 698 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 440 | 486 | 500 | 649 |
| Operating Profit | 21 | 210 | 243 | 129 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | -193 | -64 | -48 | -53 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -192 | -75 | -24 | -70 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -192 | -75 | -24 | -69 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -192 | -75 | -24 | -69 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.777 | -0.303 | -0.097 | -0.279 |